Mereo BioPharma Group plc
MREO
$2.17
-$0.08-3.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.23% | -10.18% | -10.49% | -13.31% | -7.90% |
| Total Receivables | -59.03% | 56.26% | -13.93% | -2.00% | 40.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -54.75% | -29.98% | 396.36% | -88.70% | 66.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 311.69% | 5.79% | -79.40% | 322.20% | -83.99% |
| Total Current Assets | -14.68% | -8.19% | -10.52% | -13.79% | -7.68% |
|
|
|||||
| Total Current Assets | -14.68% | -8.19% | -10.52% | -13.79% | -7.68% |
| Net Property, Plant & Equipment | -25.41% | -14.84% | -11.69% | -19.61% | -7.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 36.81% | -15.16% | -13.84% | -19.52% | -7.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -14.42% | -8.33% | -10.56% | -13.92% | -7.68% |
|
|
|||||
| Total Accounts Payable | -21.02% | -61.02% | 18.17% | 34.90% | -43.41% |
| Total Accrued Expenses | -18.89% | 65.90% | -29.67% | -18.03% | -7.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -33.94% | -19.54% | -88.03% | -0.72% | 12.07% |
| Total Finance Division Other Current Liabilities | -18.09% | 4.03% | 4.20% | -0.28% | 7.19% |
| Total Other Current Liabilities | -18.09% | 4.03% | 4.20% | -0.28% | 7.19% |
| Total Current Liabilities | -20.39% | 0.80% | -45.86% | -2.53% | -8.13% |
|
|
|||||
| Total Current Liabilities | -20.39% | 0.80% | -45.86% | -2.53% | -8.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -52.54% | -28.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.14% | 20.56% | -46.32% | -13.81% | 10.06% |
| Total Liabilities | -17.15% | 2.58% | -46.56% | -4.87% | -7.26% |
|
|
|||||
| Common Stock & APIC | 0.31% | 0.38% | 0.87% | 0.60% | 0.32% |
| Retained Earnings | -1.44% | -3.10% | -1.98% | -1.55% | -3.40% |
| Treasury Stock & Other | -26.23% | 43.47% | 18.88% | -69.75% | 39.25% |
| Total Common Equity | -13.99% | -9.83% | -1.46% | -15.95% | -7.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.99% | -9.83% | -1.46% | -15.95% | -7.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.99% | -9.83% | -1.46% | -15.95% | -7.77% |
|
|
|||||